Stay updated on Anti-PD1 Combo with Tisagenlecleucel in ALL Clinical Trial

Sign up to get notified when there's something new on the Anti-PD1 Combo with Tisagenlecleucel in ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-PD1 Combo with Tisagenlecleucel in ALL Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer now displays software revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-31T12:41:51.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A sitewide NIH notice says that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.8%
    Check dated 2026-10-24T12:28:33.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-17T13:29:45.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1. The study record history remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-10T13:19:49.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    In the Study Record Versions table, the label 'Find Contact Information' is updated to 'Find contact information' and the latest revision is shown as v3.7.0, representing a small text and version update in the UI.
    Difference
    0.2%
    Check dated 2026-09-19T18:32:31.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.6.6, was added to the study's history. This reflects an additional update to the record beyond the previous revision.
    Difference
    0.1%
    Check dated 2026-08-29T20:17:30.000Z thumbnail image

Stay in the know with updates to Anti-PD1 Combo with Tisagenlecleucel in ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-PD1 Combo with Tisagenlecleucel in ALL Clinical Trial page.